Benzinga's Top Upgrades

Analysts at Wells Fargo upgraded TJX Companies TJX from “market perform” to “outperform.” TJX Companies' shares closed at $43.11 yesterday. TJX Companies' trailing-twelve-month revenue is $23.77 billion. Analysts at UBS upgraded MedAssets MDAS from “neutral” to “buy.” MedAssets' stock closed at $12.72 yesterday. MedAssets' trailing-twelve-month operating margin is 13.21%. Analysts at Brean Murray upgraded Onyx Pharmaceuticals ONXX from “hold” to “buy.” Onyx Pharmaceuticals' shares closed at $44.58 yesterday. Onyx Pharmaceuticals had $599.99 million in total cash for the recent quarter. Analysts at Deutsche Bank upgraded EQT EQT from “hold” to “buy.” EQT's shares closed at $50.75 yesterday. EQT's PEG ratio is 1.54.